Press Release Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates 11 hours ago
Press Release Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease Jul 23